38 results on '"Bremell, Daniel"'
Search Results
2. Lyme neuroborreliosis with encephalitis; a systematic literature review and a Scandinavian cohort study
3. CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: a comparative study
4. Incidence of Lyme carditis and Lyme carditis as a cause of pacemaker implantation – a nationwide registry-based case control study
5. COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications
6. COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
7. COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
8. Incidence of Lyme Carditis and Lyme Carditis as a Cause of Pacemaker Implantation: A Nationwide Registry-Based Case-Control Study.
9. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick‐borne encephalitis disease severity—a multicentre study on Lithuanian and Swedish patients.
10. Neurochemical Evidence of Potential Neurotoxicity After Prophylactic Cranial Irradiation
11. Cerebrospinal fluid biomarkers in cardiac arrest survivors
12. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms
13. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
14. Adjunctive Corticosteroids for Lyme Neuroborreliosis Peripheral Facial Palsy—A Prospective Study With Historical Controls
15. COVIDENZA - A Prospective, Multicenter, Randomized PHASE II Clinical Trial of Enzalutamide Treatment to Decrease the Morbidity in Patients with Corona Virus Disease 2019 (COVID-19)
16. An easy-to-use scoring system for predicting bacteraemia with third-generation cephalosporin-resistant Enterobacterales in a low-resistance setting
17. Chlamydia trachomatis infection and persistence of human papillomavirus
18. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
19. Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review
20. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy)
21. Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
22. An easy-to-use scoring system for predicting bacteraemia with third-generation cephalosporin-resistant Enterobacterales in a low-resistance setting.
23. NO CSF BIOMARKER EVIDENCE OF PERSISTING CNS INFECTION AFTER SARS-CoV-2 INFECTION.
24. Lyme Neuroborreliosis - Diagnosis and Treatment
25. CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: A comparative study
26. The Importance Of Measuring Cerebrospinal Fluid Biomarkers In Cardiac Arrest Survivors (P1.101)
27. Automated cerebrospinal fluid cell count — New reference ranges and evaluation of its clinical use in central nervous system infections
28. Cerebrospinal fluid markers of central nervous system injury in decompression illness -- a case-controlled pilot study.
29. Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review
30. The N-terminal domain of α-dystroglycan, released as a 38kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis
31. Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy)
32. Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
33. [High-degree atrioventricular (AV) block].
34. Pivmecillinam – ett osäkert alternativ vid pyelonefrit.
35. Minska antalet borreliaserologier.
36. Replik till Läkemedelsverket: - Risken för tandbiverkningar av doxycyklin är negligerbar.
37. [Doxycycline can be given to children without risk of staining of teeth].
38. The N-terminal domain of α-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.